Diagnostic Nuclear Medicines Market

1 Study Coverage
    1.1 Diagnostic Nuclear Medicines Product Introduction
    1.2 Market by Type
        1.2.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Tc-99m
        1.2.3 F-18
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Diagnostic Nuclear Medicines Sales Estimates and Forecasts 2017-2028
    2.2 Global Diagnostic Nuclear Medicines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Diagnostic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Diagnostic Nuclear Medicines Sales by Region
        2.4.1 Global Diagnostic Nuclear Medicines Sales by Region (2017-2022)
        2.4.2 Global Sales Diagnostic Nuclear Medicines by Region (2023-2028)
    2.5 Global Diagnostic Nuclear Medicines Revenue by Region
        2.5.1 Global Diagnostic Nuclear Medicines Revenue by Region (2017-2022)
        2.5.2 Global Diagnostic Nuclear Medicines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Diagnostic Nuclear Medicines Sales by Manufacturers
        3.1.1 Global Top Diagnostic Nuclear Medicines Manufacturers by Sales (2017-2022)
        3.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diagnostic Nuclear Medicines in 2021
    3.2 Global Diagnostic Nuclear Medicines Revenue by Manufacturers
        3.2.1 Global Diagnostic Nuclear Medicines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Medicines Revenue in 2021
    3.3 Global Diagnostic Nuclear Medicines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Diagnostic Nuclear Medicines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Diagnostic Nuclear Medicines Sales by Type
        4.1.1 Global Diagnostic Nuclear Medicines Historical Sales by Type (2017-2022)
        4.1.2 Global Diagnostic Nuclear Medicines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
    4.2 Global Diagnostic Nuclear Medicines Revenue by Type
        4.2.1 Global Diagnostic Nuclear Medicines Historical Revenue by Type (2017-2022)
        4.2.2 Global Diagnostic Nuclear Medicines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    4.3 Global Diagnostic Nuclear Medicines Price by Type
        4.3.1 Global Diagnostic Nuclear Medicines Price by Type (2017-2022)
        4.3.2 Global Diagnostic Nuclear Medicines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Diagnostic Nuclear Medicines Sales by Application
        5.1.1 Global Diagnostic Nuclear Medicines Historical Sales by Application (2017-2022)
        5.1.2 Global Diagnostic Nuclear Medicines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
    5.2 Global Diagnostic Nuclear Medicines Revenue by Application
        5.2.1 Global Diagnostic Nuclear Medicines Historical Revenue by Application (2017-2022)
        5.2.2 Global Diagnostic Nuclear Medicines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    5.3 Global Diagnostic Nuclear Medicines Price by Application
        5.3.1 Global Diagnostic Nuclear Medicines Price by Application (2017-2022)
        5.3.2 Global Diagnostic Nuclear Medicines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Diagnostic Nuclear Medicines Market Size by Type
        6.1.1 North America Diagnostic Nuclear Medicines Sales by Type (2017-2028)
        6.1.2 North America Diagnostic Nuclear Medicines Revenue by Type (2017-2028)
    6.2 North America Diagnostic Nuclear Medicines Market Size by Application
        6.2.1 North America Diagnostic Nuclear Medicines Sales by Application (2017-2028)
        6.2.2 North America Diagnostic Nuclear Medicines Revenue by Application (2017-2028)
    6.3 North America Diagnostic Nuclear Medicines Market Size by Country
        6.3.1 North America Diagnostic Nuclear Medicines Sales by Country (2017-2028)
        6.3.2 North America Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Diagnostic Nuclear Medicines Market Size by Type
        7.1.1 Europe Diagnostic Nuclear Medicines Sales by Type (2017-2028)
        7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Type (2017-2028)
    7.2 Europe Diagnostic Nuclear Medicines Market Size by Application
        7.2.1 Europe Diagnostic Nuclear Medicines Sales by Application (2017-2028)
        7.2.2 Europe Diagnostic Nuclear Medicines Revenue by Application (2017-2028)
    7.3 Europe Diagnostic Nuclear Medicines Market Size by Country
        7.3.1 Europe Diagnostic Nuclear Medicines Sales by Country (2017-2028)
        7.3.2 Europe Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Diagnostic Nuclear Medicines Market Size by Type
        8.1.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Diagnostic Nuclear Medicines Revenue by Type (2017-2028)
    8.2 Asia Pacific Diagnostic Nuclear Medicines Market Size by Application
        8.2.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Diagnostic Nuclear Medicines Revenue by Application (2017-2028)
    8.3 Asia Pacific Diagnostic Nuclear Medicines Market Size by Region
        8.3.1 Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Diagnostic Nuclear Medicines Market Size by Type
        9.1.1 Latin America Diagnostic Nuclear Medicines Sales by Type (2017-2028)
        9.1.2 Latin America Diagnostic Nuclear Medicines Revenue by Type (2017-2028)
    9.2 Latin America Diagnostic Nuclear Medicines Market Size by Application
        9.2.1 Latin America Diagnostic Nuclear Medicines Sales by Application (2017-2028)
        9.2.2 Latin America Diagnostic Nuclear Medicines Revenue by Application (2017-2028)
    9.3 Latin America Diagnostic Nuclear Medicines Market Size by Country
        9.3.1 Latin America Diagnostic Nuclear Medicines Sales by Country (2017-2028)
        9.3.2 Latin America Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Diagnostic Nuclear Medicines Market Size by Type
        10.1.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Diagnostic Nuclear Medicines Market Size by Application
        10.2.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Diagnostic Nuclear Medicines Market Size by Country
        10.3.1 Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bracco Imaging
        11.1.1 Bracco Imaging Corporation Information
        11.1.2 Bracco Imaging Overview
        11.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bracco Imaging Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bracco Imaging Recent Developments
    11.2 Bayer
        11.2.1 Bayer Corporation Information
        11.2.2 Bayer Overview
        11.2.3 Bayer Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer Recent Developments
    11.3 Curium Pharmaceuticals
        11.3.1 Curium Pharmaceuticals Corporation Information
        11.3.2 Curium Pharmaceuticals Overview
        11.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Curium Pharmaceuticals Recent Developments
    11.4 Nordion
        11.4.1 Nordion Corporation Information
        11.4.2 Nordion Overview
        11.4.3 Nordion Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Nordion Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Nordion Recent Developments
    11.5 Triad Isotopes
        11.5.1 Triad Isotopes Corporation Information
        11.5.2 Triad Isotopes Overview
        11.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Triad Isotopes Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Triad Isotopes Recent Developments
    11.6 Lantheus
        11.6.1 Lantheus Corporation Information
        11.6.2 Lantheus Overview
        11.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Lantheus Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Lantheus Recent Developments
    11.7 GE Healthcare
        11.7.1 GE Healthcare Corporation Information
        11.7.2 GE Healthcare Overview
        11.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GE Healthcare Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GE Healthcare Recent Developments
    11.8 China Isotope & Radiation
        11.8.1 China Isotope & Radiation Corporation Information
        11.8.2 China Isotope & Radiation Overview
        11.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 China Isotope & Radiation Recent Developments
    11.9 Jubilant Pharma
        11.9.1 Jubilant Pharma Corporation Information
        11.9.2 Jubilant Pharma Overview
        11.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Jubilant Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Jubilant Pharma Recent Developments
    11.10 Eli Lilly
        11.10.1 Eli Lilly Corporation Information
        11.10.2 Eli Lilly Overview
        11.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Eli Lilly Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Eli Lilly Recent Developments
    11.11 Novartis
        11.11.1 Novartis Corporation Information
        11.11.2 Novartis Overview
        11.11.3 Novartis Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Novartis Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Novartis Recent Developments
    11.12 SIEMENS
        11.12.1 SIEMENS Corporation Information
        11.12.2 SIEMENS Overview
        11.12.3 SIEMENS Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 SIEMENS Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 SIEMENS Recent Developments
    11.13 Dongcheng
        11.13.1 Dongcheng Corporation Information
        11.13.2 Dongcheng Overview
        11.13.3 Dongcheng Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Dongcheng Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Dongcheng Recent Developments
    11.14 Navidea
        11.14.1 Navidea Corporation Information
        11.14.2 Navidea Overview
        11.14.3 Navidea Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Navidea Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Navidea Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Diagnostic Nuclear Medicines Industry Chain Analysis
    12.2 Diagnostic Nuclear Medicines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Diagnostic Nuclear Medicines Production Mode & Process
    12.4 Diagnostic Nuclear Medicines Sales and Marketing
        12.4.1 Diagnostic Nuclear Medicines Sales Channels
        12.4.2 Diagnostic Nuclear Medicines Distributors
    12.5 Diagnostic Nuclear Medicines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Diagnostic Nuclear Medicines Industry Trends
    13.2 Diagnostic Nuclear Medicines Market Drivers
    13.3 Diagnostic Nuclear Medicines Market Challenges
    13.4 Diagnostic Nuclear Medicines Market Restraints
14 Key Findings in The Global Diagnostic Nuclear Medicines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Tc-99m
    Table 3. Major Manufacturers of F-18
    Table 4. Major Manufacturers of Other
    Table 5. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Diagnostic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Diagnostic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
    Table 8. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2022)
    Table 9. Global Diagnostic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
    Table 10. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2023-2028)
    Table 11. Global Diagnostic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2017-2022)
    Table 13. Global Diagnostic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2023-2028)
    Table 15. Global Diagnostic Nuclear Medicines Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Diagnostic Nuclear Medicines Sales Share by Manufacturers (2017-2022)
    Table 17. Global Diagnostic Nuclear Medicines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2017-2022)
    Table 19. Diagnostic Nuclear Medicines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Diagnostic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2021)
    Table 22. Diagnostic Nuclear Medicines Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Diagnostic Nuclear Medicines Product Offered
    Table 24. Date of Manufacturers Enter into Diagnostic Nuclear Medicines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 27. Global Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 28. Global Diagnostic Nuclear Medicines Sales Share by Type (2017-2022)
    Table 29. Global Diagnostic Nuclear Medicines Sales Share by Type (2023-2028)
    Table 30. Global Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Diagnostic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Diagnostic Nuclear Medicines Revenue Share by Type (2017-2022)
    Table 33. Global Diagnostic Nuclear Medicines Revenue Share by Type (2023-2028)
    Table 34. Diagnostic Nuclear Medicines Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Diagnostic Nuclear Medicines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 37. Global Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 38. Global Diagnostic Nuclear Medicines Sales Share by Application (2017-2022)
    Table 39. Global Diagnostic Nuclear Medicines Sales Share by Application (2023-2028)
    Table 40. Global Diagnostic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Diagnostic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Diagnostic Nuclear Medicines Revenue Share by Application (2017-2022)
    Table 43. Global Diagnostic Nuclear Medicines Revenue Share by Application (2023-2028)
    Table 44. Diagnostic Nuclear Medicines Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Diagnostic Nuclear Medicines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 47. North America Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 48. North America Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Diagnostic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 51. North America Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 52. North America Diagnostic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Diagnostic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 55. North America Diagnostic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 56. North America Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Diagnostic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Diagnostic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Diagnostic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Diagnostic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Diagnostic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Diagnostic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Diagnostic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Diagnostic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Diagnostic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Diagnostic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Diagnostic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Diagnostic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Diagnostic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Diagnostic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Diagnostic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Diagnostic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Diagnostic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Diagnostic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Diagnostic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Diagnostic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Diagnostic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Diagnostic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Bracco Imaging Corporation Information
    Table 107. Bracco Imaging Description and Major Businesses
    Table 108. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Bracco Imaging Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Bracco Imaging Recent Developments
    Table 111. Bayer Corporation Information
    Table 112. Bayer Description and Major Businesses
    Table 113. Bayer Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Bayer Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Bayer Recent Developments
    Table 116. Curium Pharmaceuticals Corporation Information
    Table 117. Curium Pharmaceuticals Description and Major Businesses
    Table 118. Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Curium Pharmaceuticals Recent Developments
    Table 121. Nordion Corporation Information
    Table 122. Nordion Description and Major Businesses
    Table 123. Nordion Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Nordion Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Nordion Recent Developments
    Table 126. Triad Isotopes Corporation Information
    Table 127. Triad Isotopes Description and Major Businesses
    Table 128. Triad Isotopes Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Triad Isotopes Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Triad Isotopes Recent Developments
    Table 131. Lantheus Corporation Information
    Table 132. Lantheus Description and Major Businesses
    Table 133. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Lantheus Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Lantheus Recent Developments
    Table 136. GE Healthcare Corporation Information
    Table 137. GE Healthcare Description and Major Businesses
    Table 138. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. GE Healthcare Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. GE Healthcare Recent Developments
    Table 141. China Isotope & Radiation Corporation Information
    Table 142. China Isotope & Radiation Description and Major Businesses
    Table 143. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. China Isotope & Radiation Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. China Isotope & Radiation Recent Developments
    Table 146. Jubilant Pharma Corporation Information
    Table 147. Jubilant Pharma Description and Major Businesses
    Table 148. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Jubilant Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Jubilant Pharma Recent Developments
    Table 151. Eli Lilly Corporation Information
    Table 152. Eli Lilly Description and Major Businesses
    Table 153. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Eli Lilly Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Eli Lilly Recent Developments
    Table 156. Novartis Corporation Information
    Table 157. Novartis Description and Major Businesses
    Table 158. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Novartis Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Novartis Recent Developments
    Table 161. SIEMENS Corporation Information
    Table 162. SIEMENS Description and Major Businesses
    Table 163. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. SIEMENS Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. SIEMENS Recent Developments
    Table 166. Dongcheng Corporation Information
    Table 167. Dongcheng Description and Major Businesses
    Table 168. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 169. Dongcheng Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Dongcheng Recent Developments
    Table 171. Navidea Corporation Information
    Table 172. Navidea Description and Major Businesses
    Table 173. Navidea Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 174. Navidea Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. Navidea Recent Developments
    Table 176. Key Raw Materials Lists
    Table 177. Raw Materials Key Suppliers Lists
    Table 178. Diagnostic Nuclear Medicines Distributors List
    Table 179. Diagnostic Nuclear Medicines Customers List
    Table 180. Diagnostic Nuclear Medicines Market Trends
    Table 181. Diagnostic Nuclear Medicines Market Drivers
    Table 182. Diagnostic Nuclear Medicines Market Challenges
    Table 183. Diagnostic Nuclear Medicines Market Restraints
    Table 184. Research Programs/Design for This Report
    Table 185. Key Data Information from Secondary Sources
    Table 186. Key Data Information from Primary Sources
List of Figures
    Figure 1. Diagnostic Nuclear Medicines Product Picture
    Figure 3. Global Diagnostic Nuclear Medicines Market Share by Type in 2021 & 2028
    Figure 3. Tc-99m Product Picture
    Figure 4. F-18 Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Diagnostic Nuclear Medicines Market Share by Application in 2021 & 2028
    Figure 7. Oncology
    Figure 8. Cardiology
    Figure 9. Other
    Figure 10. Diagnostic Nuclear Medicines Report Years Considered
    Figure 11. Global Diagnostic Nuclear Medicines Sales 2017-2028 (K Units)
    Figure 12. Global Diagnostic Nuclear Medicines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Diagnostic Nuclear Medicines Revenue 2017-2028 (US$ Million)
    Figure 14. Global Diagnostic Nuclear Medicines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2017-2022)
    Figure 16. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2023-2028)
    Figure 17. North America Diagnostic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Diagnostic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Diagnostic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Diagnostic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Diagnostic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Diagnostic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Diagnostic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Diagnostic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Diagnostic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Diagnostic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Diagnostic Nuclear Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Diagnostic Nuclear Medicines in the World: Market Share by Diagnostic Nuclear Medicines Revenue in 2021
    Figure 29. Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 31. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 32. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 33. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 34. North America Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 35. North America Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 36. North America Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 37. North America Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 38. North America Diagnostic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 39. North America Diagnostic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 40. U.S. Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 43. Europe Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 45. Europe Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Diagnostic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 47. Europe Diagnostic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 48. Germany Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 49. France Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Diagnostic Nuclear Medicines Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Diagnostic Nuclear Medicines Revenue Share by Region (2017-2028)
    Figure 59. China Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 62. India Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Diagnostic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 74. Latin America Diagnostic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 75. Mexico Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Diagnostic Nuclear Medicines Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Diagnostic Nuclear Medicines Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Diagnostic Nuclear Medicines Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Diagnostic Nuclear Medicines Revenue Share by Country (2017-2028)
    Figure 84. Turkey Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Diagnostic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
    Figure 87. Diagnostic Nuclear Medicines Value Chain
    Figure 88. Diagnostic Nuclear Medicines Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed